The impact of therapeutic-dose induced intestinal enrofloxacin concentrations in healthy pigs on fecal Escherichia coli populations
Open Access
- 8 October 2020
- journal article
- research article
- Published by Springer Nature in BMC Veterinary Research
- Vol. 16 (1) , 1-12
Abstract
Background: Knowledge of therapy-induced intestinal tract concentrations of antimicrobials allows for interpretation and prediction of antimicrobial resistance selection within the intestinal microbiota. This study describes the impact of three different doses of enrofloxacin (ENR) and two different administration routes on the intestinal concentration of ENR and on the fecal Escherichia coli populations in pigs. Enrofloxacin was administered on three consecutive days to four different treatment groups. The groups either received an oral bolus administration of ENR (conventional or half dose) or an intramuscular administration (conventional or double dose). Results: Quantitative analysis of fecal samples showed high ENR concentrations in all groups, ranging from 5.114 ± 1.272 μg/g up to 39.54 ± 10.43 μg/g at the end of the treatment period. In addition, analysis of the luminal intestinal content revealed an increase of ENR concentration from the proximal to the distal intestinal tract segments, with no significant effect of administration route. Fecal samples were also screened for resistance in E. coli isolates against ENR. Wild-type (MIC≤0.125 μg/mL) and non-wild-type (0.125 < MIC≤2 μg/mL) E. coli isolates were found at time 0 h. At the end of treatment (3 days) only non-wild-type isolates (MIC≥32 μg/mL) were found. Conclusions: In conclusion, the observed intestinal ENR concentrations in all groups showed to be both theoretically (based on pharmacokinetic and pharmacodynamic principles) and effectively (in vivo measurement) capable of significantly reducing the intestinal E. coli wild-type population.Keywords
Funding Information
- FOD Volksgezondheid, Veiligheid van de Voedselketen en Leefmilieu (RF 14/6287 DOSERESIST)
This publication has 48 references indexed in Scilit:
- Exploiting bacterial DNA gyrase as a drug target: current state and perspectivesApplied Microbiology and Biotechnology, 2011
- Persistence of antibiotic resistance in bacterial populationsFEMS Microbiology Reviews, 2011
- Long-term impacts of antibiotic exposure on the human intestinal microbiotaMicrobiology, 2010
- Evidence of Increasing Antibiotic Resistance Gene Abundances in Archived Soils since 1940Environmental Science & Technology, 2009
- Coprevalence of Plasmid-Mediated Quinolone Resistance Determinants QepA, Qnr, and AAC(6′)-Ib-cr among 16S rRNA Methylase RmtB-Producing Escherichia coli Isolates from PigsAntimicrobial Agents and Chemotherapy, 2008
- Impact of Three Ampicillin Dosage Regimens on Selection of Ampicillin Resistance in Enterobacteriaceae and Excretion of bla TEM Genes in Swine FecesApplied and Environmental Microbiology, 2007
- Does the use of antibiotics in food animals pose a risk to human health? A reply to criticsJournal of Antimicrobial Chemotherapy, 2004
- Comparison between capillary electrophoresis, liquid chromatography, potentiometric and spectrophotometric techniques for evaluation of pKa values of zwitterionic drugs in acetonitrile–water mixturesAnalytica Chimica Acta, 2001
- Active intestinal elimination of ciprofloxacin in rats: modulation by different substratesBritish Journal of Pharmacology, 1999
- Effect of Quinolones on Intestinal EcologyDrugs, 1999